Standard dosing ranges from 0.25 to 0.5 mg daily, while micro-dosing protocols typically use 0.1 to 0.15 mg injected subcutaneously once or twice daily
In those patients, addressing the underlying metabolic dysfunction first, through dietary intervention, GLP-1 therapy if indicated, or NAD+ support for cellular energy metabolism, is the clinical priority
Injectable Therapeutic PeptidesAn Adjunct to Regenerative Medicine and Sports Performance
The primary alternatives to GHK-Cu include BPC-157, Matrixyl (Palmitoyl Pentapeptide-4)
This clinical study demonstrates that even within normal ranges, lower Vitamin B12 status is associated with impaired neurological function, slower processing speed, and increased markers of brain aging in older adults
Research without Compromise